comparemela.com
Home
Live Updates
Nippon Shinyaku : UCB Japan Obtained Additional Application
Nippon Shinyaku : UCB Japan Obtained Additional Application
Nippon Shinyaku : UCB Japan Obtained Additional Application of Fintepla® (fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Japan -March 26, 2024 at 03:06 am EDT
NEWS RELEASE
March 26, 2024
UCB Japan Obtained Additional Application of Fintepla®
for the Treatment of Seizures...
Related Keywords
Tokyo ,
Japan ,
Brussels ,
Bruxelles Capitale ,
Belgium ,
Kyoto ,
Japanese ,
Toru Nakai ,
Kanako Kikuchi ,
Zogenix Inc ,
Japan Co ,
Corporate Communications Dept ,
Ministry Of Health ,
Nippon Shinyaku Co Ltd ,
Obtained Additional Application ,
Seizures Associated ,
Gastaut Syndrome ,
Nippon Shinyaku ,
Oral Solution ,
Communications Dept ,
Markets ,